A multianalyte assay panel with cell-bound complement activation products demonstrates clinical utility in systemic lupus erythematosus
Crossref DOI link: https://doi.org/10.1136/lupus-2021-000528
Published Online: 2021-07-12
Published Print: 2021-07
Update policy: https://doi.org/10.1136/crossmarkpolicy
Alexander, Roberta Vezza https://orcid.org/0000-0001-8827-8637
Rey, Daniel Scott
Conklin, John
Domingues, Vinicius
Ahmed, Mansoor
Qureshi, Jazibeh
Weinstein, Arthur
Funding for this research was provided by:
Exagen Inc.
License valid from 2021-07-11